☆ 4.8 Article

Relative infectiousness of SARS-CoV-2 vaccine breakthrough infections, reinfections, and primary infections

NATURE COMMUNICATIONS (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Immunology

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infectivity by Viral Load, S Gene Variants and Demographic Factors, and the Utility of Lateral Flow Devices to Prevent Transmission

Lennard Y. W. Lee et al.

Summary: The study found that the infectivity of SARS-CoV-2 varies with case viral load, contact event type, and age. Those with high viral loads are the most infectious. The B.1.1.7 variant increases transmission by 50%. The best performing LFDs can detect most infectious cases.

CLINICAL INFECTIOUS DISEASES (2022)

添加到收藏夹

Editorial Material Immunology

Indirect Protection by Reducing Transmission: Ending the Pandemic With Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination

Aaron Richterman et al.

OPEN FORUM INFECTIOUS DISEASES (2022)

添加到收藏夹

Review Biochemistry & Molecular Biology

COVID-19 vaccines: where we stand and challenges ahead

Guido Forni et al.

Summary: The development of vaccines has made significant progress, but still faces various challenges, including different target populations, immunological adaptability of vaccines, and production and distribution issues. To ensure equitable access, protection of diverse subjects, and immunity against viral variants, multiple vaccines may be needed in the long run.

CELL DEATH AND DIFFERENTIATION (2021)

添加到收藏夹

Article Immunology

Assessment of the Risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection in an Intense Reexposure Setting

Laith J. Abu-Raddad et al.

Summary: A study in Qatar found a low rate of reinfection with SARS-CoV-2, with most cases being asymptomatic and suggesting protective immunity lasting for at least a few months post primary infection.

CLINICAL INFECTIOUS DISEASES (2021)

添加到收藏夹

Article Medicine, General & Internal

Association of Prior SARS-CoV-2 Infection With Risk of Breakthrough Infection Following mRNA Vaccination in Qatar

Laith J. Abu-Raddad et al.

Summary: This study aimed to assess the protection against breakthrough infection with SARS-CoV-2 after mRNA vaccination, comparing individuals with and without prior infection. The findings showed that individuals with prior SARS-CoV-2 infection had a significantly lower risk for breakthrough infection, indicating a potential benefit of natural immunity in vaccine protection.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

添加到收藏夹

Article Public, Environmental & Occupational Health

Emergence of SARS-CoV-2 B.1.1.7 Lineage — United States, December 29, 2020–January 12, 2021

Summer E. Galloway et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)

添加到收藏夹

Article Infectious Diseases

Two prolonged viremic SARS-CoV-2 infections with conserved viral genome for two months

Laith J. Abu-Raddad et al.

Summary: We report two cases of viremic and prolonged active infection with SARS-CoV-2 where the viral genome remained stable for two months, but with minimal or no symptoms. Clearance of infection occurred 40 and 41 days after detectable antibodies appeared in each case. These cases were incidentally identified during an investigation on reinfection among a cohort of 133,266 laboratory-confirmed infected individuals.

INFECTION GENETICS AND EVOLUTION (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

BNT162b2 and mRNA-1273 COVID-19 vaccine effectiveness against the SARS-CoV-2 Delta variant in Qatar

Patrick Tang et al.

Summary: mRNA COVID-19 vaccines demonstrate high effectiveness in preventing severe outcomes and death caused by the Delta variant in Qatar, despite lower effectiveness at blocking infection.

NATURE MEDICINE (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK

Koen B. Pouwels et al.

Summary: A large, community-based study in the United Kingdom indicates that the effectiveness of BNT162b2 and ChAdOx1 vaccines against SARS-CoV-2 infections with symptoms or high viral burden is reduced with the Delta variant compared to the Alpha variant. Although the effectiveness of two doses is at least as great as protection afforded by prior natural infection, there are significant differences in the dynamics of immunity after the second dose between BNT162b2 and ChAdOx1.

NATURE MEDICINE (2021)

添加到收藏夹

Letter Medicine, General & Internal

Severity of SARS-CoV-2 Reinfections as Compared with Primary Infections

Laith J. Abu-Raddad et al.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Letter Medicine, General & Internal

Efficacy of Natural Immunity against SARS-CoV-2 Reinfection with the Beta Variant

Hiam Chemaitelly et al.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Medicine, General & Internal

Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar

Hiam Chemaitelly et al.

Summary: In a study conducted in Qatar involving over 900,000 participants, vaccine effectiveness peaked at 77.5% in the first month after the second dose. However, it declined afterwards to as low as 20% in months 5 through 7 after vaccination, while protection against severe Covid-19 remained above 90% for at least 6 months.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Infectious Diseases

Transmission of COVID-19 in 282 clusters in Catalonia, Spain: a cohort study

Michael Marks et al.

Summary: The viral load of index cases is a key driver of SARS-CoV-2 transmission, while the viral load of contacts at baseline is strongly associated with the risk of developing symptomatic COVID-19 and shortening the incubation period in a dose-dependent manner.

LANCET INFECTIOUS DISEASES (2021)

添加到收藏夹

Article Medicine, General & Internal

Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study

Robert Challen et al.

Summary: The study found that the mortality hazard ratio associated with infection with VOC-202012/1 compared with previously circulating variants was 1.64, indicating an increase in deaths from 2.5 to 4.1 per 1000 detected cases in comparatively low risk group of covid-19 patients in the community. This suggests that infection with VOC-202012/1 may lead to substantial additional mortality compared with previously circulating variants, impacting healthcare capacity planning and control policies.

BMJ-BRITISH MEDICAL JOURNAL (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Correlation of SARS-CoV-2-breakthrough infections to time-from-vaccine

Barak Mizrahi et al.

Summary: The study indicates preliminary evidence of waning vaccine effectiveness of BNT162b2 among all age groups above 16, with a higher incidence of infection in those vaccinated earlier in 2021. Further investigation into long-term protection against different strains is warranted.

NATURE COMMUNICATIONS (2021)

添加到收藏夹

Article Public, Environmental & Occupational Health

Mathematical modeling of the SARS-CoV-2 epidemic in Qatar and its impact on the national response to COVID-19

Houssein H. Ayoub et al.

Summary: Mathematical modeling and forecasting successfully guided Qatar's national response to the epidemic, effectively reducing the impact on the healthcare system and bringing the epidemic under control.

JOURNAL OF GLOBAL HEALTH (2021)

添加到收藏夹

Article Medicine, General & Internal

Introduction and expansion of the SARS-CoV-2 B.1.1.7 variant and reinfections in Qatar: A nationally representative cohort study

Laith J. Abu-Raddad et al.

Summary: The novel SARS-CoV-2 variant B.1.1.7 (Alpha) can cause a significant epidemic wave when introduced into a naive population, but individuals with prior infections have strong immunity against reinfection with B.1.1.7.

PLOS MEDICINE (2021)

添加到收藏夹

Article Medicine, General & Internal

Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: a population-level observational study

Christian Holm Hansen et al.

Summary: The study investigated the protection against SARS-CoV-2 reinfection, with results showing an 80.5% protection rate for individuals previously infected. Even in the population aged 65 years and older, the protection rate against reinfection reached 47.1%, with no significant differences observed by gender or time since infection.

LANCET (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Initial report of decreased SARS-CoV-2 viral load after inoculation with the BNT162b2 vaccine

Matan Levine-Tiefenbrun et al.

Summary: COVID-19 vaccines not only provide protection to individual vaccinees, but may also reduce viral load in breakthrough infections, potentially leading to lower infectiousness and further suppressing virus spread.

NATURE MEDICINE (2021)

添加到收藏夹

Letter Medicine, General & Internal

Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants

Laith J. Abu-Raddad et al.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Characterizing the Qatar advanced-phase SARS-CoV-2 epidemic

Laith J. Abu-Raddad et al.

Summary: The study provided descriptive epidemiology of the SARS-CoV-2 epidemic in Qatar, showing age as the strongest predictor of severe, critical, or fatal infection. Most cases were asymptomatic. The rapid decline in cases was attributed to the growing immunity levels in the population.

SCIENTIFIC REPORTS (2021)

添加到收藏夹

Article Critical Care Medicine

SARS-CoV-2 seropositivity and subsequent infection risk in healthy young adults: a prospective cohort study

Andrew Letizia et al.

Summary: Young adults with SARS-CoV-2 antibodies have about one-fifth the risk of subsequent infection compared to those without antibodies. While antibodies from initial infection offer protection, they do not guarantee effective neutralization or immunity against future infection. These findings could impact mass vaccination strategies.

LANCET RESPIRATORY MEDICINE (2021)

添加到收藏夹

Article Immunology

SARS-CoV-2 Infection Is at Herd Immunity in the Majority Segment of the Population of Qatar

Mohamed H. Al-Thani et al.

Summary: Six in every 10 craft and manual workers in Qatar have been infected with COVID-19, suggesting the herd immunity threshold has been reached. The severity rate of infections was low, with the majority of infections being asymptomatic or mild.

OPEN FORUM INFECTIOUS DISEASES (2021)

添加到收藏夹

Article Infectious Diseases

Real-Time SARS-CoV-2 Genotyping by High-Throughput Multiplex PCR Reveals the Epidemiology of the Variants of Concern in Qatar

Mohammad R. Hasan et al.

Summary: This study successfully characterized the transmission dynamics of the Alpha, Beta, and Delta variants of SARS-CoV-2 in Qatar between April and June 2021 using PCR genotyping and Sanger sequencing techniques.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)

添加到收藏夹

Letter Medicine, General & Internal

Associations of Vaccination and of Prior Infection With Positive PCR Test Results for SARS-CoV-2 in Airline Passengers Arriving in Qatar

Roberto Bertollini et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

添加到收藏夹

Article Pathology

Information Technology,x and Operations,{ Tulane University, New Orleans, Louisiana

Di Tian et al.

Summary: The viral load or cycle threshold (Ct value) cannot accurately predict individual-level viral transmissibility. A sensitive method to detect the presence of virus is needed to identify potential infectious asymptomatic individuals.

JOURNAL OF MOLECULAR DIAGNOSTICS (2021)

添加到收藏夹

Editorial Material Public, Environmental & Occupational Health

Pfizer-BioNTech mRNA BNT162b2 Covid-19 vaccine protection against variants of concern after one versus two doses

Laith J. Abu-Raddad et al.

JOURNAL OF TRAVEL MEDICINE (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

mRNA-1273 COVID-19 vaccine effectiveness against the B.1.1.7 and B.1.351 variants and severe COVID-19 disease in Qatar

Hiam Chemaitelly et al.

Summary: A study showed that the mRNA-1273 vaccine is highly effective against the B.1.1.7 and B.1.351 variants of concern, with efficacy rates of 100% and 96.4% respectively. The vaccine's effectiveness increases rapidly in the weeks following the first dose, reaching maximum efficacy after the second dose, providing strong protection against severe COVID-19 outcomes.

NATURE MEDICINE (2021)

添加到收藏夹

Letter Medicine, General & Internal

Resurgence of SARS-CoV-2 Infection in a Highly Vaccinated Health System Workforce

Jocelyn Keehner et al.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Medicine, General & Internal

Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines

Mark G. Thompson et al.

Summary: The study demonstrated that COVID-19 mRNA vaccines were highly effective in preventing SARS-CoV-2 infection in real-world conditions, while also attenuating the viral RNA load, febrile symptoms, and illness duration among vaccinated individuals who had breakthrough infections.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Immunology

Interpreting vaccine efficacy trial results for infection and transmission

Marc Lipsitch et al.

Summary: Randomized controlled trials have demonstrated the efficacy of various vaccines against COVID-19, with recent studies also showing effectiveness against infection and transmission. By estimating viral positivity, a measure of prevalence, vaccine effectiveness against transmission can be assessed, providing a lower bound. These methods can be translated into observational studies to further evaluate vaccine effectiveness.

VACCINE (2021)

添加到收藏夹

Editorial Material Virology

SARS-CoV-2, CT-Values, and Infectivity-Conclusions to Be Drawn from Side Observations

Martin Platten et al.

VIRUSES-BASEL (2021)

添加到收藏夹

Article Public, Environmental & Occupational Health

COVID-19 Vaccine Breakthrough Infections Reported to CDC - United States, January 1-April 30, 2021

Meseret Birhane et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)

添加到收藏夹

Article Multidisciplinary Sciences

SARS-CoV-2 seroprevalence in the urban population of Qatar: An analysis of antibody testing on a sample of 112,941 individuals

Peter Coyle et al.

Summary: The study found that less than two in every 10 individuals in Qatar's urban population had detectable antibodies against SARS-CoV-2, indicating that herd immunity is still far off and there is a risk of subsequent infection waves. Higher antibody titers may serve as a biomarker of repeated exposures to the infection.

ISCIENCE (2021)

添加到收藏夹

Article Medicine, General & Internal

SARS-CoV-2 antibody-positivity protects against reinfection for at least seven months with 95% efficacy

Laith J. Abu-Raddad et al.

Summary: The study shows that reinfection is rare in Qatar's young and international population, with natural infection providing strong protection against reinfection with an estimated efficacy of around 95% for at least seven months. Reinfections are often less severe than primary infections.

ECLINICALMEDICINE (2021)

添加到收藏夹

Review Infectious Diseases

SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis

Muge Cevik et al.

Summary: This study aimed to characterize the viral load dynamics, duration of viral shedding, and viable virus shedding of SARS-CoV-2 in various body fluids. The findings suggest that while SARS-CoV-2 RNA shedding can be prolonged in respiratory and stool samples, the duration of viable virus shedding is relatively short-lived.

LANCET MICROBE (2021)

添加到收藏夹

Article Immunology

Predicting Infectious Severe Acute Respiratory Syndrome Coronavirus 2 From Diagnostic Samples

Jared Bullard et al.

CLINICAL INFECTIOUS DISEASES (2020)

添加到收藏夹

Article Infectious Diseases

Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards

Bernard La Scola et al.

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2020)

添加到收藏夹

Article Microbiology

Development and Validation of the Elecsys Anti-SARS-CoV-2 Immunoassay as a Highly Specific Tool for Determining Past Exposure to SARS-CoV-2

Peter Muench et al.

JOURNAL OF CLINICAL MICROBIOLOGY (2020)

添加到收藏夹

Review Medicine, General & Internal

Molecular and Serological Tests for COVID-19. A Comparative Review of SARS-CoV-2 Coronavirus Laboratory and Point-of-Care Diagnostics

Robert Kubina et al.

DIAGNOSTICS (2020)

添加到收藏夹

Letter Medicine, General & Internal

Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host

Bina Choi et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

添加到收藏夹

Article Medicine, General & Internal

Multi-center nationwide comparison of seven serology assays reveals a SARS-CoV-2 non-responding seronegative subpopulation

Kfir Oved et al.

ECLINICALMEDICINE (2020)

添加到收藏夹

Article Immunology

Epidemiological Impact of SARS-CoV-2 Vaccination: Mathematical Modeling Analyses

Monia Makhoul et al.

VACCINES (2020)

添加到收藏夹

Article Immunology

Determinants of Per-Coital-Act HIV-1 Infectivity Among African HIV-1-Serodiscordant Couples

James P. Hughes et al.

JOURNAL OF INFECTIOUS DISEASES (2012)

添加到收藏夹

Article Medicine, General & Internal

Viral load and heterosexual transmission of human immunodeficiency virus type 1

TC Quinn et al.

NEW ENGLAND JOURNAL OF MEDICINE (2000)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.